A randomized, open-label, phase II study of lapatinib / capecitabine, lapatinib / vinorelbine, or lapatinib / gemcitabine in patients with ErbB2-amplified metastatic breast cancer... von Gomez, Henry Leonidas, Neciosup, Silvia P., Tosello, Celia, Xavier, Patricia, Neron do Nascimento, Yeni, Fanelli, Marcelo, Ismael, Gustavo, Bines, Jose, Sampaio, Carlos, Lerzo, Guillermo Luis, Capo, Adolfo Miguel, Mano, Max S., Fein, Luis, Werutsky, Gustavo, Barrios, Carlos H.

Volltext